1Amand IS,Fisher LD,Chiang YT,et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the valsartan heart failure trial[J]. Circulation,2003 ;107:1278-83.
2Cheng VL,Kazanagra R,Garcia A,et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admired for decompensated heart failure:a pilot study[J]. J Am Coil Cardiol,2001 ;7:386-91.
3James SK,Lindahl B,Siegbahn A,et al. N-terminal-pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease:a Global Utilization of Strategies To Open occlude arteries( GUSTO)-Ⅳ substudy[ J]. Circulation ,2003 ;108:275-81.
4Wieczorek SJ, Wu AHB, Christenson R, et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure : a multicenter evaluation [ J ]. Am Heart J,2002 ; 144 : 834 -9.
5Dan Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-Type natriuretic peptide(BNP) in the diagnosis of CHF in an urgent care setting[ J]. J Am Coll Cardiol,2001 ;37:379-85.
6Maisel A, Krishnaswamy P, Nowak R, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure[ J]. N Engl J Med,2002 ;347 : 161-7.
9Lainchbury JG, Campbell E, Frampton CM,et al. Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patient with acute shortness of breath [ J ]. J Am Coil Cardiol, 2003 ;42:728-35.
10Mockel M, Muller R, Vollert JO ,et al. Role of N-terminal Pro-B-type na triuretic peptide in risk stratification in patients presenting in the emer gency room[J]. Clin Chem,2005 ;51:1624-31.
二级参考文献23
1Collins SP, Ronan-Bentle S, Storrow AB. Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspnea. Ann Emerg Med ,2003,41:532-545.
2Shapiro BP, Chen HH, Burnett JC Jr, et al. Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure. Mayo Clin Proc, 2003,78:481-486.
3Tjeerdsma G, de Boer RA, Boomsma F, et al. Rapid bedside measurement of brain natriuretie peptide in patients with chronic heart failure. Int J Cardiol,2002,86 : 143-149.
4Latini R, Masson S, de Angelis N, et al. Role of brain natriuretic peptide in the diagnosis and management of heart failure: current concepts. J Card Fail, 2002,8:288-299.
5Logeart D. Ultra-rapid measurement of brain natriuretic peptide.Arch Mal Coeur Vaiss, 2002,95:185-188.
6Peacock WF 4th. The B-type natriuretie peptide assay : a rapid test for heart failure. Cleve Clin J Med,2002 ,69 :243-251.
7Valli N, Georges A, Corcuff JB, et al. Assessment of brain natriuretic peptide in patients with suspected heart failure :comparison with radionuclide ventriculography data. Clin Chim Acta,2001,306 : 19-26.
8Nicholls MG, Lainchbury JG, Richards AM, et al. Brain natriuretic peptide-guided therapy for heart failure. Ann Med, 2001,33 : 422-427.
9Sodian R, Ixcbe M, Schmitt C, et al. Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems. J Am CoN Cardiol, 2001,38 : 1942-1949.
10Richards AM, Nicholls MG, Espiner EA, et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation ,2003,107:2786-2792.
